Cities around the globe are struggling to meet the needs of their citizens with respect to food, energy and water. These three sectors are inextricably linked and actions in one sector more often have impacts in one or both of the others; these interacting sectors can therefore be seen as a Food-Energy-Water Nexus (FEW Nexus) of systems. The ERANET Sustainable Urbanisation Global Initiative (EN-SUGI) will bring together the fragmented research and innovation expertise across Europe and beyond to find innovative new solutions to this FEW Nexus challenge. Furthermore, by linking the activity of the Joint Programming Initiative (JPI) Urban Europe and the Belmont Forum (BF), EN-SUGI develops more resilient, applied urban solutions that bring research and innovation together from across the globe. EN-SUGI is a project that foresees the participation of 19 Funding Agencies eligible for the EU top up, 18 from JPI Urban Europe and 1 from Argentina, and 6 FAs non eligible for EU top up, under the umbrella of the Belmont forum , collaborating on a volunteer base. EN-SUGI Main objectives and impacts are: To support development of practical innovations and new collaborative research that will allow urban areas to understand and address the challenges of the Food-Energy-Water systems. (Impact = 12-14 projects funded, and 15 cities/local authorities engaged) To provide a framework for aligning R&I agendas of JPI Urban Europe and the BF,. The alignment will help foster transdisciplinary collaboration and co-creation in research and innovation, and facilitate the use of global expertise and knowledge (Impact = 24 funding organisations involved) EN-SUGI will foster development of international relationships between the different parts of the research and innovation community – to enable them to contribute to addressing those challenges and goals, while aligning them to wider, strategic initiatives, including the SRIA agenda, Future Earth and UN –Habitat.

EP PerMed is a new European Partnership dedicated to Personalised Medicine (PM). It supports PM-related R&I, but also facilitates and accelerates all steps so that PM achievements successfully pass through the full value continuum to be implemented in sustainable health systems for the benefit of people and societies. The partnership will foster demonstration projects and promote successes and lessons learned to demonstrate evidence of PM implementation. EP PerMed activities cover overarching aspects, like patient involvement, exchange with medical societies, infrastructures and international and regional collaboration. The project portfolios of EP PerMed and ERA PerMed (ERA-Net co-fund on PM) and others are supported to become successful innovations in healthcare practice. EP PerMed will be the global PM-platform for scientific and strategic dialogue and alignment, resulting in public documents and publications. Accordingly, it will inform the public, patients, healthcare providers or payers about the latest PM options and engage them. The Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM, 2023), developed by EP PerMed partners, is the basis for the partnership's structure and a wide range of its activities. All steps of the SRIA development were strongly support by numerous PM-experts, stakeholders and the European Commission (EC). Thus, the EP PerMed annual Joint Transnational Calls (JTCs) and other funding and activities, events and tools will be in line with the SRIA and outputs will feed into a SRIA update in the coming years. The partnership builds on several developments, initiatives and projects such as ERA PerMed, ICPerMed and its supporting projects (“ICPerMed Family”) funded by the EC. In parallel, it reaches out to the 1+Million Genomes Initiative, other European Partnerships in the Health Cluster and infrastructures like the European Strategy Forum on Research Infrastructures (ESFRI).